Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanism.
Times cited: 42
Bcl-x(L) is phosphorylated in malignant cells following microtubule disruption.
Times cited: 147
Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization.
Journal of Biological Chemistry.
Times cited: 592